Interestingly, the other two studies focused on colorectal cancer and prostate cancer conducted by the same group (Fritzsche et al.)showed that in colorectal cancer AGR2’s up-regulation was strongly associated with improved OS compared with the control, while no prognostic value of AGR2 could be detected in prostate cancer17,19. Here, AGR2 is linked to prostate carcinoma.